- Hun Jee Choe, Hyunsuk Lee, DongHo Lee, Soo‐Heon Kwak, Bo Kyung Koo. Different effects of low muscle mass on the risk of non‐alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort. J cachexia sarcopenia muscle 2023;14:260

- Tiziana Fernández-Mincone, Felipe Contreras-Briceño, Maximiliano Espinosa-Ramírez, Patricio García-Valdés, Antonio López-Fuenzalida, Arnoldo Riquelme, Juan Pablo Arab, Daniel Cabrera, Marco Arrese, Francisco Barrera. Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications. Expert Review of Gastroenterology & Hepatology 2020;14:1141

- Chan-Hee Jung. Letter: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38). JOMES 2020;29:158

- Hong-Ye Peng, Shao-Jie Duan, Liang Pan, Mi-Yuan Wang, Jia-Liang Chen, Yi-Chong Wang, Shu-Kun Yao. Development and validation of machine learning models for nonalcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International 2023;22:615

- Karn Wijarnpreecha, Panadeekarn Panjawatanan, Elizabeth Aby, Aijaz Ahmed, Donghee Kim. Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity. Maturitas 2019;124:48

- Svein Ivar Bekkelund, Rolf Jorde. Alanine Aminotransferase and Body Composition in Obese Men and Women. Disease Markers 2019;2019:1

- Yun Kim. Emerging Treatment Options for Sarcopenia in Chronic Liver Disease. Life 2021;11:250

- A.F. Sheptulina, O.N. Dzhioeva, O.M. Drapkina. The relationship between sarcopenia and non-alcoholic fatty liver disease: pathophysiological and clinical aspects. Profil. med. 2021;24:104

- David J. Hanna, Scott T. Jamieson, Christine S. Lee, Christopher A. Pluskota, Nicole J. Bressler, Peter N. Benotti, Sandeep Khurana, David D. K. Rolston, Christopher D. Still. “Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”. Obesity Science & Practice 2021;7:629

- Fanny Petermann-Rocha, Stuart R. Gray, Ewan Forrest, Paul Welsh, Naveed Sattar, Carlos Celis-Morales, Frederick K. Ho, Jill P. Pell. Associations of muscle mass and grip strength with severe NAFLD: A prospective study of 333,295 UK Biobank participants. Journal of Hepatology 2022;76:1021

- Changzhou Cai, Xin Song, Yishu Chen, Xueyang Chen, Chaohui Yu. Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Hepatol Int 2020;14:115

- Merve Arı, Gülfidan Başer, Nursen İlçin. Yaşlılarda Sarkopeni ve Toplumsal Katılım. 2024;11:494

- Inha Jung, Dae-Jeong Koo, Won-Young Lee. Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective. Diabetes Metab J 2024;48:327

- Sae Kyung Joo, Won Kim. It's Ready for Targeting Muscle in Nonalcoholic Fatty Liver in This Era of Aging. Gut and Liver 2019;13:5

- Alkistis‐Maria Papatheodoridi, Lampros Chrysavgis, Michael Koutsilieris, Antonios Chatzigeorgiou. The Role of Senescence in the Development of Nonalcoholic Fatty Liver Disease and Progression to Nonalcoholic Steatohepatitis. Hepatology 2020;71:363

- Qing Ye, Biyao Zou, Yee Hui Yeo, Jie Li, Daniel Q Huang, Yuankai Wu, Hongli Yang, Chuanli Liu, Leslie Y Kam, Xiang Xuan Eunice Tan, Nicholas Chien, Sam Trinh, Linda Henry, Christopher Donald Stave, Tetsuya Hosaka, Ramsey C Cheung, Mindie H Nguyen. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2020;5:739

- Su Hwan Kim, Ji Bong Jeong, Jinwoo Kang, Dong-Won Ahn, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, Sohee Oh, Soon Ho Yoon, Sang Joon Park, Doo Hee Lee, Masaki Mogi. Association between sarcopenia level and metabolic syndrome. PLoS ONE 2021;16:e0248856

- Hong-Kyu Kim, Sung-Jin Bae, Min Jung Lee, Eun Hee Kim, Hana Park, Hwi Seung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee, Jaewon Choe. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity. Clin Mol Hepatol 2023;29:987

- Jae Woo Park, Jeong-Ju Yoo, Dong Hyeon Lee, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Log Young Kim, Jae Young Jang. Evolving epidemiology of non-alcoholic fatty liver disease in South Korea: incidence, prevalence, progression, and healthcare implications from 2010 to 2022. Korean J Intern Med 2024;39:931

- Jung A. Kim, Kyung Mook Choi. Sarcopenia and fatty liver disease. Hepatol Int 2019;13:674

- Byoung Chan Ahn, Chul Yong Park, Jung Hee Hong, Ki Ook Baek. Association between total body muscle percentage and prevalence of non-alcoholic fatty liver disease in Korean adults findings from an 18-year follow-up: a prospective cohort study. JYMS 2023;40:S47

- A. Gastaldelli. Non-Alcoholic Fatty Liver Disease. 2023.

- Amandeep Singh, Amaninder S. Dhaliwal, Shailainder Singh, Atul Kumar, Rocio Lopez, Mohit Gupta, Mazen Noureddin, William Carey, Arthur McCullough, Naim Alkhouri. Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US Cohort. Dig Dis Sci 2020;65:978

- Huajie Dai, Jiali Xiang, Yanan Hou, Liping Xuan, Tiange Wang, Mian Li, Zhiyun Zhao, Yu Xu, Jieli Lu, Yuhong Chen, Weiqing Wang, Guang Ning, Yufang Bi, Min Xu. Fat mass to fat-free mass ratio and the risk of non-alcoholic fatty liver disease and fibrosis in non-obese and obese individuals. Nutr Metab (Lond) 2021;18

- Yedidya Saiman, Andres Duarte-Rojo, Mary E. Rinella. Fatty Liver Disease: Diagnosis and Stratification. Annu. Rev. Med. 2022;73:529

- Jun-Hyuk Lee, Soyoung Jeon, Hye Sun Lee, Yu-Jin Kwon. Cutoff Points of Waist Circumference for Predicting Incident Non-Alcoholic Fatty Liver Disease in Middle-Aged and Older Korean Adults. Nutrients 2022;14:2994

- Xingxing Zhang, Zhiying He, Qiya Si, Xiang Hu, Lijuan Yang, Xiao Gu, Linjia Du, Lei Wang, Linyu Pan, Yingqian Li, Jing Li, Bo Yang, Xuejiang Gu, Ferdinando Carlo Sasso. The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus. Journal of Diabetes Research 2022;2022:1

- Wen Guo, Xin Zhao, Mengyuan Miao, Xiuru Liang, Xiaona Li, Pei Qin, Jing Lu, Wenfang Zhu, Juan Wu, Chen Zhu, Nianzhen Xu, Qun Zhang. Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease. Front. Nutr. 2022;9

- Yuping Ding, Quanjun Deng, Mei Yang, Haiyan Niu, Zuoyu Wang, Shihai Xia. Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment. DMSO 2023;Volume 16:3303

- Annalisa Cespiati, Marica Meroni, Rosa Lombardi, Giovanna Oberti, Paola Dongiovanni, Anna Ludovica Fracanzani. Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies. Biomedicines 2022;10:182

- Christian Skou Eriksen, Søren Møller. Quantitative Assessment of Body Composition in Cirrhosis. Diagnostics 2024;14:2191

- Zi Yuan Zou, Vincent Wai‐Sun Wong, Jian Gao Fan. Epidemiology of nonalcoholic fatty liver disease in non‐obese populations: Meta‐analytic assessment of its prevalence, genetic, metabolic, and histological profiles. J of Digest Diseases 2020;21:372

- Asieh Mansour, Saeed Pourhassan, Hadis Gerami, Mohammad Reza Mohajeri‐Tehrani, Marziye Salahshour, Ali Abbasi, Elham Madreseh, Sayed Mahmoud Sajjadi‐Jazi. Regional fat distribution and hepatic fibrosis and steatosis severity in patients with nonalcoholic fatty liver disease and type 2 diabetes. Obesity Science & Practice 2024;10

- Hwi Young Kim, Su Jung Baik, Hye Ah Lee, Byoung Kwon Lee, Hye Sun Lee, Tae Hun Kim, Kwon Yoo. Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease. Sci Rep 2020;10

- Guangya Chen, Yi Lv, Wei Ni, Qingxin Shi, Xingliang Xiang, Sen Li, Chengwu Song, Mingzhong Xiao, Shuna Jin. Associations between Phase Angle Values Obtained by Bioelectrical Impedance Analysis and Nonalcoholic Fatty Liver Disease in an Overweight Population. Canadian Journal of Gastroenterology and Hepatology 2020;2020:1

- Manu V. Chakravarthy, Mohammad S. Siddiqui, Mikael F. Forsgren, Arun J. Sanyal. Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis. Front. Endocrinol. 2020;11

- Kai Ushio, Yukio Mikami, Hiromune Obayashi, Hironori Fujishita, Kouki Fukuhara, Tetsuhiko Sakamitsu, Kazuhiko Hirata, Yasunari Ikuta, Hiroaki Kimura, Nobuo Adachi. Decreased Muscle-to-Fat Mass Ratio Is Associated with Low Muscular Fitness and High Alanine Aminotransferase in Children and Adolescent Boys in Organized Sports Clubs. JCM 2021;10:2272

- Goh-Eun Chung, Hyo-Eun Park, Min-Joo Kim, Min-Sun Kwak, Jong-In Yang, Su-Jin Chung, Jeong-Yoon Yim, Ji-Won Yoon. The Association between Low Muscle Mass and Hepatic Steatosis in Asymptomatic Population in Korea. Life 2021;11:848

- Inhwan Lee, Jeonghyeon Kim, Hyunsik Kang. Estimated Cardiorespiratory Fitness Attenuates the Impacts of Sarcopenia and Obesity on Non-Alcoholic Fatty Liver in Korean Adults. IJERPH 2020;17:3902

- Maobin Kuang, Jiajun Qiu, Dongdong Li, Chong Hu, Shuhua Zhang, Guotai Sheng, Yang Zou. The newly proposed Metabolic Score for Visceral Fat is a reliable tool for identifying non-alcoholic fatty liver disease, requiring attention to age-specific effects in both sexes. Front. Endocrinol. 2023;14

- Goh Eun Chung, Min Joo Kim, Jeong Yoon Yim, Joo Sung Kim, Ji Won Yoon. Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease. JOMES 2019;28:129

- Stergios A. Polyzos, Ilias D. Vachliotis, Christos S. Mantzoros. Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease. Metabolism 2023;147:155676

- Sae Kyung Joo, Won Kim. Interaction between sarcopenia and nonalcoholic fatty liver disease. Clin Mol Hepatol 2023;29:S68

- Fengqin Yan, Guqiao Nie, Nianli Zhou, Meng Zhang, Wen Peng. Association of fat-to-muscle ratio with non-alcoholic fatty liver disease: a single-centre retrospective study. BMJ Open 2023;13:e072489

- Yoowon Kwon, Su Jin Jeong. Relative Skeletal Muscle Mass Is an Important Factor in Non-Alcoholic Fatty Liver Disease in Non-Obese Children and Adolescents. JCM 2020;9:3355

- Dong Hyun Sinn, Danbee Kang, Mira Kang, Eliseo Guallar, Yun Soo Hong, Kyung Hyun Lee, Jiyeon Park, Juhee Cho, Geum‐Youn Gwak. Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study. Hepatology 2022;76:1746

- Stefano Ballestri, Alessandro Mantovani, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo. Extra-Hepatic Manifestations and Complications of Nonalcoholic Fatty Liver Disease. Future Med. Chem. 2019;11:2171

- Yi Long, Yi Wu, Yanbiao Zhong, Yanlin Wu, Hua Ye, Yu Luo, Li Xiao, Yixuan Ma, Maoyuan Wang. Resveratrol as a potential therapeutic agent for sarcopenic obesity: Insights from in vivoperiments. Biomedicine & Pharmacotherapy 2024;179:117396

- Maha Hoteit, Myriam Dagher, Nikolaos Tzenios, Najat Al Kaaki, Ghadir Rkein, Abdul Rahman Chahine, Yonna Sacre, Samer Hotayt, Rami Matar, Mahmoud Hallal, Micheal Maitar, Bilal Hotayt. Influence of Sugar-Sweetened Beverages Intake on Sarcopenic Obesity, Visceral Obesity, and Sarcopenia in Lebanese Patients with MASLD: A Case-Control Study. Healthcare 2024;12:591

- Eun Roh, Soon Young Hwang, Hye Jin Yoo, Sei Hyun Baik, Jin-Hee Lee, Sang Joon Son, Hyeon Ju Kim, Yong Soon Park, Sam-Gyu Lee, Be Long Cho, Hak Chul Jang, Bong Jo Kim, Miji Kim, Chang Won Won, Kyung Mook Choi. Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study. Hepatol Int 2022;16:545

- Xiaoyan Li, Jie He, Qiuhua Sun. The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis. Clinical Nutrition 2024;43:2005

- Goh Eun Chung, Ji Won Yoon. Response: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38). JOMES 2020;29:160

- Jun-Hyuk Lee, Hye-Sun Lee, Byoung-Kwon Lee, Yu-Jin Kwon, Ji-Won Lee. Relationship between Muscle Mass and Non-Alcoholic Fatty Liver Disease. Biology 2021;10:122

- Joana Rigor, Matilde Monteiro-Soares, Pedro Barata, Daniela Martins-Mendes. How Sarcopenia, Muscle Mass, Strength, and Performance Relate to Non-Alcoholic Fatty Liver Disease: A Systematic Review. Sci 2024;6:59

- Yong-ho Lee, Seung Up Kim. Sarcopenia: an emerging risk factor for non-alcoholic fatty liver disease. Hepatol Int 2020;14:5

- Alessandra Musio, Federica Perazza, Laura Leoni, Bernardo Stefanini, Elton Dajti, Renata Menozzi, Maria Letizia Petroni, Antonio Colecchia, Federico Ravaioli. Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease. IJMS 2023;24:7517

- Xiao-Yan Pan, Wen-Yue Liu, Pei-Wu Zhu, Gang Li, Liang-Jie Tang, Feng Gao, Ou-Yang Huang, Hai-Yang Yuan, Giovanni Targher, Christopher D. Byrne, Xiao-Dong Wang, Ming-Hua Zheng. Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty liver disease in male. Hepatol Int 2022;16:1085

- Vittoria Zambon Azevedo, Cristina Alina Silaghi, Thomas Maurel, Horatiu Silaghi, Vlad Ratziu, Raluca Pais. Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease. Front. Nutr. 2022;8

- Zhuojun Xin, Jiaojiao Huang, Qiuyu Cao, Jialu Wang, Ruixin He, Tianzhichao Hou, Yi Ding, Jieli Lu, Min Xu, Tiange Wang, Zhiyun Zhao, Weiqing Wang, Guang Ning, Yufang Bi, Yu Xu, Mian Li. Nonalcoholic fatty liver disease in relation to the remission and progression along the glycemic continuum. Journal of Diabetes 2022;14:606

- Omar El Sherif, Amritpal Dhaliwal, Philip N Newsome, Matthew J Armstrong. Sarcopenia in nonalcoholic fatty liver disease: new challenges for clinical practice. Expert Review of Gastroenterology & Hepatology 2020;14:197

- Jovana Milic, Valentina Menozzi, Filippo Schepis, Andrea Malagoli, Giulia Besutti, Iacopo Franconi, Alessandro Raimondi, Federica Carli, Cristina Mussini, Giada Sebastiani, Giovanni Guaraldi. Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV. 2020;34:1915

- Su Hwan Kim, Hyoun Woo Kang, Ji Bong Jeong, Dong Seok Lee, Dong-Won Ahn, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, Sohee Oh, Soon Ho Yoon, Sang Joon Park, Mauro Lombardo. Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study. PLoS ONE 2021;16:e0256083

- Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho. KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease. Clin Mol Hepatol 2021;27:363

- Ivana Mikolasevic, Tajana Pavic, Tajana Filipec Kanizaj, Darija Vranesic Bender, Viktor Domislovic, Zeljko Krznaric, Branka Filipović. Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?. Canadian Journal of Gastroenterology and Hepatology 2020;2020:1

- Vincent W.S. Wong, Shira Zelber‐Sagi, Kenneth Cusi, Patrizia Carrieri, Eugene Wright, Javier Crespo, Jeffrey V. Lazarus. Management of NAFLD in primary care settings. Liver International 2022;42:2377
